Trial Profile
Phase II Evaluation of Docetaxel Combined With Estramustine Phosphate in Patients With Metastatic Breast Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Sep 2005
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Estramustine (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 08 Sep 2005 New trial record.